Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT01168921 · COMPLETED
Trial details
- NCT number
- NCT01168921
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-03
- Primary completion
- 2022-03-07
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.